|4Jan 31, 4:26 PM ET

Singh Vanila 4

4 · Virpax Pharmaceuticals, Inc. · Filed Jan 31, 2024

Insider Transaction Report

Form 4
Period: 2024-01-29
Singh Vanila
Director
Transactions
  • Award

    Stock Option (right to buy)

    2024-01-29+25,00025,000 total
    Exercise: $0.32Exp: 2034-01-28Common Stock (25,000 underlying)
Footnotes (1)
  • [F1]These options vest pro rata on a monthly basis for 12 months commencing one year after the date of grant.

Documents

2 files